Abstract
Circulating tumor DNA (ctDNA) represents a promising tool for diagnosis, prognosis and treatment monitoring of several malignant diseases. We aimed to investigate ctDNA as an early marker of response to treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have